Risk-benefit/cost-benefit
Subtitle: improving government regulation of approval of new drugs
By: remarks by Rita Ricardo-Campbell, presented at the World Congress on Health and Economics [i.e. World Congress on Health Economics] Leyden University, Leyden, The Netherlands, September 9, 1980.
Publisher: Hoover Institution, Stanford University
Published: 1980
Place of publication: [Sanford, Calif.]
Language: eng
Number of pages: 21
Subjects: Pharmaceutical policy -- United States.; Drugs -- Testing -- Government policy -- United States.; Drugs -- Cost effectiveness.; Drugs -- United States -- Cost effectiveness.
Notes: Includes bibliographical references.